These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2987 related items for PubMed ID: 25945007

  • 1. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.
    World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007
    [Abstract] [Full Text] [Related]

  • 2. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S, Rhim H, Kim YS, Kang TW, Song KD.
    Liver Int; 2016 Apr 28; 36(4):580-7. PubMed ID: 26503910
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
    Gao F, Zhu HK, Zhu YB, Shan QN, Ling Q, Wei XY, Xie HY, Zhou L, Xu X, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2016 Aug 28; 15(4):371-7. PubMed ID: 27498576
    [Abstract] [Full Text] [Related]

  • 4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 28; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 5. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
    Chon YE, Choi GH, Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY.
    Int J Cancer; 2012 Nov 15; 131(10):2332-41. PubMed ID: 22362471
    [Abstract] [Full Text] [Related]

  • 6. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 7. Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
    Yamao T, Yamashita YI, Imai K, Umezaki N, Tsukamoto M, Kitano Y, Arima K, Miyata T, Nakagawa S, Okabe H, Hayashi H, Chikamoto A, Ishiko T, Baba H.
    Anticancer Res; 2019 Feb 15; 39(2):883-889. PubMed ID: 30711971
    [Abstract] [Full Text] [Related]

  • 8. The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.
    Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K.
    Surg Today; 2015 Dec 15; 45(12):1513-20. PubMed ID: 25527455
    [Abstract] [Full Text] [Related]

  • 9. Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
    Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K.
    Cancer; 1996 Nov 15; 78(10):2094-100. PubMed ID: 8918402
    [Abstract] [Full Text] [Related]

  • 10. Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.
    Kaibori M, Matsui Y, Yanagida H, Yokoigawa N, Kwon AH, Kamiyama Y.
    World J Surg; 2004 Jul 15; 28(7):702-7. PubMed ID: 15185000
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C.
    PLoS One; 2016 Jul 15; 11(4):e0153227. PubMed ID: 27070780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
    Hamamura K, Shiratori Y, Shiina S, Imamura M, Obi S, Sato S, Yoshida H, Omata M.
    Cancer; 2000 Apr 01; 88(7):1557-64. PubMed ID: 10738213
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
    Lee YK, Kim SU, Kim DY, Ahn SH, Lee KH, Lee DY, Han KH, Chon CY, Park JY.
    BMC Cancer; 2013 Jan 03; 13():5. PubMed ID: 23282286
    [Abstract] [Full Text] [Related]

  • 15. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T, Orimo T, Wakayama K, Shimada S, Nagatsu A, Yokoo H, Kamachi H, Yamashita K, Shimamura T, Taketomi A.
    World J Surg Oncol; 2017 Aug 22; 15(1):156. PubMed ID: 28830473
    [Abstract] [Full Text] [Related]

  • 16. Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.
    Lee MH, Kim SU, Kim DY, Ahn SH, Choi EH, Lee KH, Lee DY, Seong J, Han KH, Chon CY, Park JY.
    J Gastroenterol Hepatol; 2012 Feb 22; 27(2):313-22. PubMed ID: 21793906
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2002 Jul 22; 17(7):772-8. PubMed ID: 12121507
    [Abstract] [Full Text] [Related]

  • 18. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL, Liu LP, Yang S, Liu L, Ren JW, Fang X, Chen GG, Lai PB.
    Br J Surg; 2016 May 22; 103(6):716-724. PubMed ID: 26996727
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH, You YK.
    World J Gastroenterol; 2014 Dec 07; 20(45):17132-40. PubMed ID: 25493027
    [Abstract] [Full Text] [Related]

  • 20. The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
    Tsugawa D, Fukumoto T, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Koyama T, Ku Y.
    Kobe J Med Sci; 2015 Mar 07; 61(5):E124-31. PubMed ID: 27363395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 150.